2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-ureidopentanoic acid

Catalog No. :
ACPBYK468
CAS No. :
161125-34-4
Molecular Formula :
C21H23N3O5
Molecular Weight :
397.43

IUPAC Name:2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-ureidopentanoic acid

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-ureidopentanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$155.00Login to see priceInquiryInquiry
5g98%$466.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-ureidopentanoic acid
IUPAC Name2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-ureidopentanoic acid
MDL No.MFCD02682429
Molecular FormulaC21H23N3O5
Molecular Weight397.43
SMILESO=C(N)NCCCC(C(O)=O)NC(OCC1C2=CC=CC=C2C3=CC=CC=C13)=O
InChI KeyNBMSMZSRTIOFOK-UHFFFAOYSA-N
SynonymFMOC-DL-CITRULLINE;RARECHEM EM WB 0092;2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-5-UREIDOPENTANOIC ACID;5-(carbamoylamino)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanoic acid;Ornithine, N5-(aminocarbonyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-
CAS No.161125-34-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPBYK468 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSQLW302 route compound structure diagram
    ACSQLW302627-77-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPBYK468 route product structure diagram
    ACPBYK468161125-34-4
Inquiry

2. ACPBYK468 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPBYK468 route product structure diagram
    ACPBYK468161125-34-4
Inquiry

Comments (0)